89bio, Inc. (ETNB)

89bio Statistics

Total Valuation

89bio has a market cap or net worth of $1.42 billion. The enterprise value is $851.34 million.

Market Cap	1.42B
Enterprise Value	851.34M

Important Dates

The next estimated earnings date is Monday, August 4, 2025, after market close.

Earnings Date	Aug 4, 2025
Ex-Dividend Date	n/a

Share Statistics

89bio has 145.98 million shares outstanding. The number of shares has increased by 43.38% in one year.

Current Share Class	145.98M
Shares Outstanding	145.98M
Shares Change (YoY)	+43.38%
Shares Change (QoQ)	+26.22%
Owned by Insiders (%)	0.59%
Owned by Institutions (%)	76.29%
Float	101.58M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.40
P/TBV Ratio	2.40
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 18.03, with a Debt / Equity ratio of 0.06.

Current Ratio	18.03
Quick Ratio	16.86
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-70.83

Financial Efficiency

Return on equity (ROE) is -69.30% and return on invested capital (ROIC) is -42.69%.

Return on Equity (ROE)	-69.30%
Return on Assets (ROA)	-39.93%
Return on Invested Capital (ROIC)	-42.69%
Return on Capital Employed (ROCE)	-62.32%
Revenue Per Employee	n/a
Profits Per Employee	-$4.16M
Employee Count	93
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, 89bio has paid $732,000 in taxes.

Income Tax	732,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +26.59% in the last 52 weeks. The beta is 1.53, so 89bio's price volatility has been higher than the market average.

Beta (5Y)	1.53
52-Week Price Change	+26.59%
50-Day Moving Average	8.70
200-Day Moving Average	8.36
Relative Strength Index (RSI)	55.55
Average Volume (20 Days)	2,184,087

Short Selling Information

The latest short interest is 13.99 million, so 9.58% of the outstanding shares have been sold short.

Short Interest	13.99M
Short Previous Month	13.93M
Short % of Shares Out	9.58%
Short % of Float	13.77%
Short Ratio (days to cover)	5.79

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-403.29M
Pretax Income	-170.51M
Net Income	-386.67M
EBITDA	-403.25M
EBIT	-403.29M
Earnings Per Share (EPS)	-$3.30

Balance Sheet

The company has $638.78 million in cash and $37.58 million in debt, giving a net cash position of $601.20 million or $4.12 per share.

Cash & Cash Equivalents	638.78M
Total Debt	37.58M
Net Cash	601.20M
Net Cash Per Share	$4.12
Equity (Book Value)	605.46M
Book Value Per Share	4.15
Working Capital	645.06M

Cash Flow

In the last 12 months, operating cash flow was -$399.84 million and capital expenditures -$87,000, giving a free cash flow of -$399.93 million.

Operating Cash Flow	-399.84M
Capital Expenditures	-87,000
Free Cash Flow	-399.93M
FCF Per Share	-$2.74

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

89bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-43.38%
Shareholder Yield	-43.38%
Earnings Yield	-26.62%
FCF Yield	-27.53%

Analyst Forecast

The average price target for 89bio is $26.43, which is 172.47% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$26.43
Price Target Difference	172.47%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1